Target
Tyrosine-protein kinase JAK2 [826-1132]
Ligand
BDBM604254
Substrate
n/a
Meas. Tech.
JAK2 LanthaScreen JH1 Binding Assay
IC50
<100±n/a nM
Citation
 Liu, KDouty, BLevy, DWu, LYao, WYue, EW Tricyclic urea compounds as JAK2 V617F inhibitors US Patent  US11661422 Publication Date 5/30/2023 
Target
Name:
Tyrosine-protein kinase JAK2 [826-1132]
Synonyms:
JAK2 | JAK2_HUMAN | Tyrosine-protein kinase JAK2 (826-1132) | Tyrosine-protein kinase JAK2 JH1 (826-1132)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
35849.63
Organism:
Homo sapiens (Human)
Description:
aa 826-1132
Residue:
307
Sequence:
RIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
  
Inhibitor
Name:
BDBM604254
Synonyms:
US11661422, Example 2
Type:
Small organic molecule
Emp. Form.:
C29H31N5O3S
Mol. Mass.:
529.653
SMILES:
CN1C(=O)N(Cc2c1cnc1[nH]c(cc21)-c1ccc(CN2CCC(CC2)S(C)(=O)=O)cc1)c1ccccc1
Structure:
Search PDB for entries with ligand similarity: